Skip to content

Author

Hui-Ling Luo

We have 3 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Neurological adverse events associated with immune checkpoint inhibitors: a pharmacovigilance study based on the FAERS and JADER databases

Neurological adverse events (NAEs) have been reported during immune checkpoint inhibitor (ICI) therapy, but their reporting spectrum and onset patterns across drugs and pharmacovigilance databases remain incompletely characterized. We conducted a pharmacovigilance study of seven ICIs using the FDA Adverse Ev...

Hui-Ling Luo, Xian-Long Xie, Shi-Ran Qin et al. · 0 citations
Review Open access Oct 2026

Neutrophil dysregulation in sepsis-induced acute lung injury: mechanistic framework and therapeutic targeting by natural products

The molecular determinants underlying neutrophil functional heterogeneity are summarized, the dual role of neutrophils in host defense and tissue injury in SALI is discussed, and emerging evidence that natural products can alleviate SALI by modulating neutrophil recruitment, oxidative stress, inflammatory signaling, an...

Hui-Ling Luo, Jin-Yuan Lin, Hong-Lei Shen et al. · 0 citations
Sep 2026

TDP-43 Post-transcriptionally Regulates SLC7A7 to Promote Ferroptosis and Metabolic Dysfunction-Associated Steatohepatitis upon Arsenic Exposure.

Findings delineate a crucial TDP-43/SLC7A7/Ferroptosis axis in arsenic-induced liver injury, highlighting a post-transcriptional regulatory function of TDP-43 in mediating environmental metabolic toxicity.

Hui-Ling Luo, Wen-Juan Tan, Qi Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.